PTEN‐PI3K pathway alterations in advanced prostate cancer and clinical implications
Author:
Affiliation:
1. Dana‐Farber Cancer Institute Boston Massachusetts USA
2. Harvard Medical School Boston Massachusetts USA
Publisher
Wiley
Subject
Urology,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24372
Reference113 articles.
1. Cancer statistics, 2020
2. Abiraterone and Increased Survival in Metastatic Prostate Cancer
3. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
4. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
5. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other Diseases;Recent Patents on Anti-Cancer Drug Discovery;2024-05
2. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02
3. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis;Molecular Oncology;2024-01-15
4. Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers;Cancer Research Communications;2023-11-20
5. Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities;Research and Reports in Urology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3